STAT3 and neoplasm: In B16STAT3β tumor-bearing mice, LPS had a less potent decreasing effect on the number of splenic CD8 T cells than in B16NC tumor-bearing mice (Fig. 5d), suggesting a role of STAT3 activation in LPS-induced splenic CD8 T cell reduction.